Press Releases

 

All Releases | Reset Search
Acquisitions | Business/Product | Corporate | Financial

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
DateTitle 
05/14/13Hospira Reappoints Dr. Sumant Ramachandra Chief Scientific OfficerPrinter Friendly Version
05/08/13Hospira Convenes Its 2013 Annual Meeting of ShareholdersPrinter Friendly Version
05/01/13Hospira Reports First-Quarter 2013 ResultsPrinter Friendly Version
05/01/13Hospira Unveils Global Device StrategyPrinter Friendly Version
04/24/13Hospira Marks Five Years of Biosimilars Success at 2013 BIO International ConventionPrinter Friendly Version
04/17/13Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
04/15/13Hospira Names Matthew R. Stober Senior Vice President of OperationsPrinter Friendly Version
04/02/13Hospira to Host Conference Call for First-Quarter 2013 ResultsPrinter Friendly Version
03/18/13Hospira Obtains Six Months U.S. Pediatric Exclusivity for Precedex™ (dexmedetomidine HCl) InjectionPrinter Friendly Version
03/18/13Hospira Statement on Rocky Mount Plant InspectionPrinter Friendly Version
03/01/13Hospira Announces Executive ChangesPrinter Friendly Version
02/13/13Hospira Reports Fourth-Quarter and Full-Year 2012 ResultsPrinter Friendly Version
02/05/13Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
01/23/13Hospira's TheraDoc™ Infection Control Assistant Ranked #1 in Its Category in the Latest "Best in KLAS" ReportPrinter Friendly Version
01/22/13Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion SystemPrinter Friendly Version
12/20/12Hospira to Host Conference Call for Fourth-Quarter 2012 Results and 2013 ProjectionsPrinter Friendly Version
12/10/12Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013Printer Friendly Version
11/07/12Hospira Reports Third-Quarter 2012 ResultsPrinter Friendly Version
10/18/12Statement on Drug Shortages and Quality Commitment by Hospira CEO Mike BallPrinter Friendly Version
10/05/12Hospira to Host Conference Call for Third-quarter 2012 ResultsPrinter Friendly Version
08/30/12Hospira to Present at the UBS Global Life Sciences Conference Sept. 20, 2012Printer Friendly Version
08/29/12Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D FacilitiesPrinter Friendly Version
08/14/12Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
08/09/12Hospira Announces U.S. Re-Launch Of Generic Oxaliplatin InjectionPrinter Friendly Version
08/01/12Hospira Reports Second-Quarter 2012 ResultsPrinter Friendly Version
07/31/12Hospira Expands Board of Directors With Election of Dennis M. FentonPrinter Friendly Version
06/29/12Hospira to Host Conference Call for Second-quarter 2012 ResultsPrinter Friendly Version
06/29/12Hospira and Lancaster General Hospital Honored for Patient Safety InitiativesPrinter Friendly Version
06/11/12Hospira Introduces Enhanced TheraDoc™ Clinical Surveillance System to Help Hospitals Improve Patient Outcomes and Better Manage Antibiotic UsePrinter Friendly Version
05/24/12I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, ProcessPrinter Friendly Version
05/21/12 Hospira Announces Important Safety Information Regarding Carpuject Syringe System and the Potential For OverfillPrinter Friendly Version
05/09/12Hospira Convenes Its 2012 Annual Meeting of ShareholdersPrinter Friendly Version
05/08/12Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
05/01/12Hospira Reports First-Quarter 2012 ResultsPrinter Friendly Version
04/26/12Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care ConferencePrinter Friendly Version
04/12/12Hospira Infusion Pumps Ranked Top Devices in New KLAS Smart Pumps 2012 ReportPrinter Friendly Version
04/11/12Hospira Names John B. Elliot Senior Vice President of OperationsPrinter Friendly Version
04/02/12Hospira to Host Conference Call for First-quarter 2012 ResultsPrinter Friendly Version
03/09/12Hospira's TheraDoc(TM) Clinical Surveillance System to Support Infection Prevention and Patient Safety Efforts at CHRISTUS HealthPrinter Friendly Version
03/08/12Hospira Receives FDA Clearance for Symbiq(TM) 3.13 Infusion PumpPrinter Friendly Version
02/23/12Hospira Joins the Generic Pharmaceutical AssociationPrinter Friendly Version
02/22/12Hospira to Present at the Barclays Capital Global Healthcare ConferencePrinter Friendly Version
02/21/12Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Month's Supply of New Product Immediately and on Track to Ensure Sustainable SupplyPrinter Friendly Version
02/14/12Hospira Working With Urgency to Help Address Methotrexate ShortagePrinter Friendly Version
02/14/12Hospira Reports Fourth-Quarter and Full-Year 2011 ResultsPrinter Friendly Version
02/13/12Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry TalentPrinter Friendly Version
02/10/12Hospira Commends FDA on Draft Biosimilars GuidelinesPrinter Friendly Version
01/30/12Hospira Names Richard Davies Chief Commercial OfficerPrinter Friendly Version
01/19/12Hospira named a Top 50 Organization for Multicultural Business OpportunitiesPrinter Friendly Version
01/16/12Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 ProjectionsPrinter Friendly Version
01/09/12Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical ProgramPrinter Friendly Version
12/22/11Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 ProjectionsPrinter Friendly Version
12/14/11Hospira to Present at the J.P. Morgan 30th Annual Healthcare Conference Jan. 10, 2012Printer Friendly Version
12/07/11Hospira Board Announces Retirement of Executive Chairman and Former CEO Christopher B. Begley; Names John C. Staley ChairmanPrinter Friendly Version
11/16/11Hospira Announces U.S. Launch of Imipenem-Cilastatin for Injection, I.V.Printer Friendly Version
10/31/11Hospira Supports President Obama on Drug ShortagesPrinter Friendly Version
10/26/11Hospira Reports Third-Quarter 2011 ResultsPrinter Friendly Version
10/18/11Hospira Announces Certain Preliminary Third-Quarter 2011 ResultsPrinter Friendly Version
09/27/11Hospira to Host Conference Call for Third-Quarter 2011 ResultsPrinter Friendly Version
09/19/11Hospira named one of America’s Best Adoption-Friendly WorkplacesPrinter Friendly Version
09/06/11Hospira Announces Positive Results From Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal PatientsPrinter Friendly Version
08/29/11Hospira to Host 2011 Investor DayPrinter Friendly Version
08/18/11Hospira to Present at the Morgan Stanley Global Healthcare ConferencePrinter Friendly Version
08/17/11Hospira Expands Board of DirectorsPrinter Friendly Version
08/05/11Hospira Announces U.S. Approval of Solution Version of Gemcitabine InjectionPrinter Friendly Version
07/27/11Hospira Reports Second-Quarter 2011 ResultsPrinter Friendly Version
06/29/11Hospira Applauds North Carolina's New Legislation Aimed at Reducing Healthcare-Associated InfectionsPrinter Friendly Version
06/27/11Hospira to Host Conference Call for Second-Quarter 2011 ResultsPrinter Friendly Version
05/23/11DSS and Hospira Win Veterans Affairs Industry Innovation Award for TheraDoc(TM) Clinical Surveillance SystemPrinter Friendly Version
05/20/11Hospira to Present at the Goldman Sachs 32nd Annual Global Healthcare ConferencePrinter Friendly Version
05/20/11Hospira Receives Health Canada Regulatory Approval for Symbiq(TM) Infusion System Software UpgradePrinter Friendly Version
05/12/11Hospira to Present at the Sanford C. Bernstein Twenty-Seventh Annual Strategic Decisions Conference 2011Printer Friendly Version
05/10/11Hospira Highlights Progress in 2010 at Its 2011 Annual Meeting of ShareholdersPrinter Friendly Version
04/28/11WellSpan Health, Cerner and Hospira Honored with 2011 Way-Paver Award for Excellence in Barcode-Enabled Patient SafetyPrinter Friendly Version
04/26/11Hospira Reports First-Quarter 2011 ResultsPrinter Friendly Version
04/25/11Hospira Board Authorizes $1 Billion Share Repurchase ProgramPrinter Friendly Version
04/11/11Hospira to Present at Bank of America / Merrill Lynch 2011 Health Care Conference May 11, 2011Printer Friendly Version
04/07/11Hospira Reinforces Importance of Clinical Surveillance Technology in Line With World Health Day Focus on Antimicrobial ResistancePrinter Friendly Version
04/04/11Hospira to Host Conference Call for First-Quarter 2011 ResultsPrinter Friendly Version
04/04/11Hospira Submits 510(k) Application to FDA for Symbiq(TM) Infusion System ModificationsPrinter Friendly Version
04/01/11Hospira Launches Enhanced TheraDoc(TM) Clinical Surveillance System to Support Patient Safety and Help Improve CarePrinter Friendly Version
03/17/11Hospira Supports Disaster Relief Efforts in JapanPrinter Friendly Version
03/09/11Hospira Announces U.S. Approval of Generic DocetaxelPrinter Friendly Version
03/07/11Hospira Board Names F. Michael Ball New CEO; Christopher B. Begley to Assume Executive Chairman RolePrinter Friendly Version
03/03/11Hospira Launches New U.S. Product Website Detailing Entire PortfolioPrinter Friendly Version
02/23/11Hospira MedNet(TM) Portal Safety Software Benchmarking System Debuts at HIMSSPrinter Friendly Version
02/14/11Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
02/03/11Hospira Announces FDA Approval of Topotecan InjectionPrinter Friendly Version
02/02/11Hospira Reports Fourth-Quarter and Full-Year 2010 ResultsPrinter Friendly Version
01/25/11Hospira to Host Conference Call for Fourth-Quarter 2010 Results and 2011 ProjectionsPrinter Friendly Version
01/21/11Hospira Statement Regarding Pentothal™ (sodium thiopental) Market Exit Printer Friendly Version
12/15/10Hospira to Host Conference Call for Fourth-Quarter 2010 Results and 2011 ProjectionsPrinter Friendly Version
12/13/10Hospira to Present at J.P. Morgan 29th Annual Healthcare Conference Jan. 11, 2011Printer Friendly Version
11/22/10Hospira Names Francois L. Dubois Senior Vice President of QualityPrinter Friendly Version
11/15/10Hospira Launches Gemcitabine HCL for InjectionPrinter Friendly Version
11/02/10Hospira to Present at Piper Jaffray 22nd Annual Health Care Conference Nov. 30Printer Friendly Version
10/26/10Hospira Reports Third-Quarter 2010 ResultsPrinter Friendly Version
10/21/10Hospira Launches Piperacillin and Tazobactam for Injection in the United StatesPrinter Friendly Version
10/07/10Hospira Announces New Contracts in Effect with Novation for Infusion Pumps, Solutions and EquipmentPrinter Friendly Version
09/27/10Hospira to Host Conference Call for Third-Quarter 2010 ResultsPrinter Friendly Version
09/26/10Hospira Receives TGA Approval for Nivestim(TM), Australia's First Biosimilar FilgrastimPrinter Friendly Version
09/09/10Hospira and Smiths Medical to Co-Promote Infusion Pumps and Develop a Standardized Safety Monitoring and Reporting Solution across Infusion SystemsPrinter Friendly Version
08/26/10Hospira to Present at Morgan Stanley Global Healthcare Conference Sept. 13Printer Friendly Version
08/22/10Hospira Japan Receives Approval for New Indication for 'Precedex IV(TM) 200ug'Printer Friendly Version
08/20/10Hospira Announces CEO Succession PlanPrinter Friendly Version
08/12/10Hospira to Host Biosimilars Investor Education EventPrinter Friendly Version
08/02/10Hospira to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference Aug. 12Printer Friendly Version
07/28/10Hospira Reports Second-Quarter 2010 ResultsPrinter Friendly Version
07/26/10Hospira Begins Phase I U.S. Clinical Trial of Biosimilar Erythropoietin in Renal PatientsPrinter Friendly Version
07/13/10Hospira TheraDoc(TM) Infection Control Assistant(TM) Documents Interventions to Help Hospital Reduce Catheter-Related InfectionsPrinter Friendly Version
07/01/10Hospira Announces Successful Completion of Tender Offer for Shares of Javelin PharmaceuticalsPrinter Friendly Version
06/28/10Hospira Announces Intention to Complete Tender Offer for Shares of Javelin PharmaceuticalsPrinter Friendly Version
06/24/10Hospira to Host Conference Call for Second-Quarter 2010 ResultsPrinter Friendly Version
06/22/10Hospira Receives FDA Approval for Meropenem for Injection, USP (I.V.)Printer Friendly Version
06/17/10Hospira Announces Further Extension of Tender Offer for Shares of Javelin PharmaceuticalsPrinter Friendly Version
06/10/10Nivestim(TM), a New Biosimilar Filgrastim, is Approved in Europe for the Prevention of Febrile Neutropenia Associated With ChemotherapyPrinter Friendly Version
06/07/10Hospira and DURECT Sign Agreement to Develop and Commercialize POSIDUR(TM) (SABER(TM)-Bupivacaine) in the U.S. and CanadaPrinter Friendly Version
06/03/10Hospira Announces Further Extension of Tender Offer for Shares of Javelin PharmaceuticalsPrinter Friendly Version
05/19/10Hospira Announces Extension of Tender Offer for Shares of Javelin PharmaceuticalsPrinter Friendly Version
05/18/10Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
05/14/10Hospira to Standardize Intravenous (I.V.) Administration Sets Portfolio to Non-DEHPPrinter Friendly Version
05/11/10Hospira Highlights a Year of Significant Progress at Its 2010 Annual Meeting of ShareholdersPrinter Friendly Version
05/10/10Hospira to Present at Citi 2010 Global Health Care Conference May 27, 2010Printer Friendly Version
05/06/10Hospira Unveils TheraDoc Anticoagulation Assistant(TM) Knowledge Module to Help Hospitals Comply With Joint Commission Patient Safety GoalPrinter Friendly Version
04/27/10Hospira Reports First-Quarter 2010 ResultsPrinter Friendly Version
04/19/10Hospira and Javelin Pharmaceuticals Enter Into Definitive Merger Agreement for Hospira to Acquire Javelin Pharmaceuticals; Hospira Will Initiate Tender OfferPrinter Friendly Version
04/07/10Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
04/01/10Hospira Announces Agreement on Oxaliplatin Patent ChallengePrinter Friendly Version
03/30/10Hospira Completes Acquisition of Orchid's Generic Injectable Pharmaceuticals BusinessPrinter Friendly Version
03/25/10Hospira to Host Conference Call for First-Quarter 2010 ResultsPrinter Friendly Version
03/05/10Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
03/02/10UAB Hospital to Integrate Advanced Symbiq(TM) Infusion Device With EHR to Enhance Safety and Clinician WorkflowPrinter Friendly Version
03/01/10HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality MeasuresPrinter Friendly Version
03/01/10HIMSS Interoperability Showcase to Feature Hospira MedNet(TM), Demonstrating Interoperability as Key to Advancing HealthcarePrinter Friendly Version
02/10/10Hospira Announces Expiration of Hart-Scott-Rodino Review Period for Acquisition of Orchid's Generic Injectable Pharmaceuticals BusinessPrinter Friendly Version
02/04/10Hospira Reports Fourth-Quarter and Full-Year 2009 ResultsPrinter Friendly Version
01/29/10Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 ProjectionsPrinter Friendly Version
01/22/10Hospira Supports Disaster Relief Efforts in Haiti With Products and Cash GrantsPrinter Friendly Version
01/11/10Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010Printer Friendly Version
12/23/09Hospira to Present at J.P. Morgan 28th Annual Healthcare Conference Jan. 13, 2010Printer Friendly Version
12/16/09Hospira to Host Conference Call for Fourth-Quarter 2009 Results and 2010 ProjectionsPrinter Friendly Version
12/15/09Hospira to Acquire Orchid's Generic Injectable Pharmaceuticals BusinessPrinter Friendly Version
12/07/09Lancaster General Hospital Releases Infusion Pump/EHR Interoperability Data - Auto Programming Provides an Additional Layer of SafetyPrinter Friendly Version
12/04/09Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. ContainersPrinter Friendly Version
12/02/09Hospira Acquires TheraDoc, Enhances Medication Safety and Infection Management OfferingsPrinter Friendly Version
11/18/09Our Lady of the Lake Connects Infusion Pumps to the EHR to Help Decrease Errors and Improve CarePrinter Friendly Version
11/06/09Hospira to Present at Piper Jaffray 21st Annual Health Care Conference Dec. 2Printer Friendly Version
10/29/09Healthcare Industry Celebrates 25 Years of Advanced Pain Management With PCA Infusion SystemPrinter Friendly Version
10/27/09Hospira Reports Third-Quarter 2009 ResultsPrinter Friendly Version
10/20/09Hospira Names Daphne E. Jones Chief Information OfficerPrinter Friendly Version
10/12/09Hospira to Present at Credit Suisse 18th Annual Healthcare Conference Nov. 11Printer Friendly Version
10/08/09Hospira, Celltrion, Enter Business Cooperation Agreement to Develop and Market Biogeneric DrugsPrinter Friendly Version
09/30/09Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVAPrinter Friendly Version
09/28/09Hospira to Host Conference Call for Third-Quarter 2009 ResultsPrinter Friendly Version
09/16/09Hospira to Present at UBS Global Life Sciences Conference Sept. 23Printer Friendly Version
09/10/09Hospira to Host 2009 Investor DayPrinter Friendly Version
08/31/09Hospira Receives FDA Approval for Six New Presentations of HeparinPrinter Friendly Version
08/11/09Hospira Launches Generic Oxaliplatin InjectionPrinter Friendly Version
07/29/09Hospira Reports Second-Quarter 2009 ResultsPrinter Friendly Version
07/09/09ICU Medical, Inc. to Acquire Hospira's Critical Care Product LinePrinter Friendly Version
06/30/09Hospira Announces New Contract With MedAssets for Intravenous Solutions, Renewal of Infusion Devices AgreementPrinter Friendly Version
06/29/09Hospira Receives FDA Approval for Azithromycin for InjectionPrinter Friendly Version
06/26/09Hospira to Host Conference Call for Second-Quarter 2009 ResultsPrinter Friendly Version
06/18/09Hospira Receives Favorable Court Decision on Eloxatin(R)Printer Friendly Version
05/20/09Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
05/19/09Hospira Announces Plans to Integrate Symbiq(R) and EndoTool(R) TechnologiesPrinter Friendly Version
05/14/09Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of ShareholdersPrinter Friendly Version
05/07/09Hospira Receives FDA Approval for 10 Gram Vial of Sterile Vancomycin Hydrochloride, USPPrinter Friendly Version
05/07/09Hospira to Present at Bank of America and Merrill Lynch 2009 Health Care Conference May 13Printer Friendly Version
05/05/09Hospira Launches Biologics 'Clock' and Web Resource to Raise Awareness of Potential Biogenerics' ImpactPrinter Friendly Version
04/28/09Hospira Reports First-Quarter 2009 ResultsPrinter Friendly Version
04/27/09Hospira Names Brian Meadows Supply Chain ChiefPrinter Friendly Version
03/30/09Hospira to Host Conference Call for First-Quarter 2009 ResultsPrinter Friendly Version
03/24/09Hospira Announces Plans to Optimize Operations, Increase Shareholder ValuePrinter Friendly Version
03/23/09Hospira to Host Investor Conference Call March 24, 2009Printer Friendly Version
03/11/09Hospira Supports Newly Introduced Biogenerics LegislationPrinter Friendly Version
03/10/09Hospira to Present at Cowen and Company's 29th Annual Health Care Conference March 17Printer Friendly Version
03/09/09Hospira Expands Board of DirectorsPrinter Friendly Version
02/25/09Hospira Advances Patient Safety With New GemStar SP Infusion SystemPrinter Friendly Version
02/17/09Hospira Reports Fourth-Quarter and Full-Year 2008 ResultsPrinter Friendly Version
02/02/09Hospira's Precedex Phase IV Study Published in the Journal of The American Medical AssociationPrinter Friendly Version
01/26/09Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 ProjectionsPrinter Friendly Version
12/29/08Hospira to Present at J.P. Morgan's 27th Annual Healthcare Conference January 14Printer Friendly Version
11/10/08Hospira Names Ken Meyers to Lead Human ResourcesPrinter Friendly Version
11/05/08Hospira Reports Third-Quarter 2008 ResultsPrinter Friendly Version
11/04/08Hospira to Present at the 2008 Annual Credit Suisse Health Care Conference on November 12Printer Friendly Version
10/30/08FDA Approves New Indication for Hospira's Precedex (Dexmedetomidine HCL) InjectionPrinter Friendly Version
10/13/08Hospira Acquires EndoTool From MD ScientificPrinter Friendly Version
10/07/08Hospira Hosts Conference Call for Third-Quarter 2008 EarningsPrinter Friendly Version
08/27/08Hospira to Present at the Morgan Stanley 2008 Healthcare Conference on September 9Printer Friendly Version
08/21/08Hospira Announces New Contracts With Premier Purchasing Partners for Infusion Devices, Solutions And EquipmentPrinter Friendly Version
08/06/08Hospira Reports Second-Quarter 2008 ResultsPrinter Friendly Version
07/07/08Hospira Hosts Conference Call for Second-Quarter 2008 EarningsPrinter Friendly Version
06/25/08Hospira Names Dr. Sumant Ramachandra Chief Scientific OfficerPrinter Friendly Version
05/21/08Hospira Supports Disaster Relief Efforts in Myanmar and ChinaPrinter Friendly Version
05/13/08Hospira Expands Board of DirectorsPrinter Friendly Version
05/13/08Hospira Highlights Strategic Initiatives at Its 2008 Annual Meeting of ShareholdersPrinter Friendly Version
05/07/08Hospira Reports First-Quarter 2008 ResultsPrinter Friendly Version
04/30/08Hospira Acquires SculptorPrinter Friendly Version
04/30/08Hospira to Present at the Bank of America 2008 Health Care Conference on May 14Printer Friendly Version
04/04/08Hospira Hosts Conference Call for First-Quarter 2008 EarningsPrinter Friendly Version
03/06/08Hospira to Present at the Bear Stearns 10th Annual London Healthcare Conference on March 13 Printer Friendly Version
02/28/08Hospira Reports Fourth-Quarter and Full-Year 2007 ResultsPrinter Friendly Version
02/27/08Hospira Launches Generic Irinotecan InjectionPrinter Friendly Version
02/26/08Hospira Announces New Contract With HealthTrust Purchasing Group for Infusion Devices, Solutions and EquipmentPrinter Friendly Version
01/17/08Hospira Hosts Conference Call For Fourth-Quarter 2007 Results and 2008 ProjectionsPrinter Friendly Version
12/26/07Hospira to Present at the JPMorgan 26th Annual Healthcare Conference on January 9Printer Friendly Version
12/19/07Hospira's Retacrit™ Receives Marketing Authorization in the EUPrinter Friendly Version
11/08/07Hospira Reports Third-Quarter 2007 ResultsPrinter Friendly Version
10/31/07Hospira to Present at the Credit Suisse Phoenix Health Care Conference on November 13Printer Friendly Version
10/18/07Hospira's Biosimilar Epoetin Retacrit™ Receives Positive Opinion Recommending EU ApprovalPrinter Friendly Version
10/03/07Hospira Hosts Conference Call for Third-Quarter 2007 EarningsPrinter Friendly Version
09/20/07Hospira Wins Most Valuable Pollution Prevention Award for VisIV™ ContainerPrinter Friendly Version
09/06/07Biogenerics Will Save Billions, Says Hospira CEOPrinter Friendly Version
08/31/07Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11Printer Friendly Version
08/08/07Hospira Reports Second-Quarter 2007 ResultsPrinter Friendly Version
07/09/07Hospira Hosts Conference Call for Second-Quarter 2007 EarningsPrinter Friendly Version
05/30/07Hospira to Host Inaugural Investor DayPrinter Friendly Version
05/15/07Hospira Highlights Strategic Progress at its 2007 Annual Meeting of ShareholdersPrinter Friendly Version
05/09/07Hospira Reports First-Quarter 2007 ResultsPrinter Friendly Version
04/06/07Hospira Hosts Conference Call for First-Quarter 2007 EarningsPrinter Friendly Version
04/04/07Hospira Introduces Advanced Wireless Security Platform for Infusion DevicesPrinter Friendly Version
02/28/07Hospira Reports Fourth-Quarter and Full-Year 2006 ResultsPrinter Friendly Version
02/22/07Hospira Announces Collaborations to Interface Hospital Technologies and Improve Patient SafetyPrinter Friendly Version
02/01/07Hospira Completes Acquisition of Mayne Pharma, Announces New Commercial Leadership StructurePrinter Friendly Version
01/30/07Hospira to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7Printer Friendly Version
01/19/07Hospira Hosts Conference Call for Fourth-Quarter 2006 Results and 2007 ProjectionsPrinter Friendly Version
01/18/07Hospira Acquisition Of Mayne Pharma Clears U.S. Antitrust ReviewPrinter Friendly Version
12/28/06Hospira to Present at the JPMorgan 25th Annual Healthcare Conference January 9Printer Friendly Version
12/26/06Hospira Launches Ondansetron InjectionPrinter Friendly Version
11/20/06Hospira, STADA and BIOCEUTICALS Enter Into Agreements for ErythropoietinPrinter Friendly Version
11/08/06Hospira Reports Third-Quarter 2006 ResultsPrinter Friendly Version
10/31/06Hospira Expands Board of DirectorsPrinter Friendly Version
10/30/06Hospira Hosts Conference Call for Third-Quarter 2006 Earnings Printer Friendly Version
10/16/06Hospira Unveils Symbiq™ Next-Generation Infusion SystemPrinter Friendly Version
10/12/06Health Alliance of Greater Cincinnati Announces Agreement With Hospira to Replace Entire Fleet of Intravenous (I.V.) Pumps Across Seven HospitalsPrinter Friendly Version
10/06/06Hospira Hosts Conference Call for Third-Quarter 2006 EarningsPrinter Friendly Version
09/26/06Hospira Signs Agreement to Provide Pain Management Infusion Pumps to Premier-Member HospitalsPrinter Friendly Version
09/20/06Hospira Announces $2 Billion Agreement to Acquire Mayne PharmaPrinter Friendly Version
09/19/06Hospira Named to Human Rights Campaign's "Best Places to Work" ListPrinter Friendly Version
09/07/06Hospira Announces New Contract With HealthTrust To Provide Pain Management Infusion Pumps To MembersPrinter Friendly Version
08/31/06Hospira To Present At The Bear Stearns 19th Annual Healthcare Conference On September 11thPrinter Friendly Version
08/14/06Hospira Foundation Grant Supports Programs to Lessen Fear and Isolation Felt by Seriously Ill ChildrenPrinter Friendly Version
08/11/06Hospira Names Thomas E. Werner as Chief Financial OfficerPrinter Friendly Version
08/09/06Hospira Reports Second-Quarter 2006 ResultsPrinter Friendly Version
07/06/06Hospira Hosts Conference Call for Second-Quarter 2006 EarningsPrinter Friendly Version
05/17/06Hospira Convenes Its Second Annual Meeting of ShareholdersPrinter Friendly Version
05/09/06Hospira Reports First-Quarter 2006 ResultsPrinter Friendly Version
04/25/06Hospira Appoints Terrence C. Kearney To Newly Created COO PositionPrinter Friendly Version
04/24/06Hospira and InnerWireless Partner to Enhance Connectivity Between Hospital Systems and Medication Management DevicesPrinter Friendly Version
04/19/06Hospira Introduces the VISIV™ Container, the First Significantly Advanced I.V. Bag in More Than 30 YearsPrinter Friendly Version
04/11/06Hospira Hosts Conference Call for First-Quarter 2006 EarningsPrinter Friendly Version
04/03/06Hospira Becomes Chicago Area's Latest FORTUNE 1000 CompanyPrinter Friendly Version
03/31/06Hospira Nominates Ronald A. Matricaria And Mark F. Wheeler For Election To BoardPrinter Friendly Version
02/28/06Hospira Reports Fourth-Quarter and Full-Year 2005 ResultsPrinter Friendly Version
02/28/06Hospira Board Authorizes $400 Million Share Repurchase ProgramPrinter Friendly Version
02/16/06Hospira Joins State Of Kansas And Kansas Bioscience Authority To Announce $60 Million Investment In McPherson Manufacturing FacilityPrinter Friendly Version
02/13/06Hospira Introduces LifeCare PCA(R) Infusion SystemPrinter Friendly Version
02/01/06Hospira Announces Further Plans To Optimize Manufacturing OperationsPrinter Friendly Version
01/31/06Hospira to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on February 7Printer Friendly Version
01/12/06Hospira Hosts Conference Call For 2006 Projections And Fourth-Quarter EarningsPrinter Friendly Version
01/05/06Hospira to Present At The JPMorgan 24th Annual Healthcare Conference On January 10Printer Friendly Version
12/12/05Hospira Introduces Plum A+®3 Infusion System With Hospira MedNet® SoftwarePrinter Friendly Version
11/10/05Hospira Reports Third-Quarter 2005 ResultsPrinter Friendly Version
11/04/05Hospira Announces Strategic Alliance With PharmaLink And Zuellig Pharma In AsiaPrinter Friendly Version
11/01/05Hospira And Cerner Announce Availability Of Point-Of-Care I.V. Medication Management SolutionPrinter Friendly Version
10/24/05Hospira Launches Next-Generation SEDLine™ Brain-Function Monitoring SystemPrinter Friendly Version
10/10/05Hospira Hosts Conference Call For Third-Quarter EarningsPrinter Friendly Version
09/07/05Hospira to Present at the Bear Stearns 18th Annual Healthcare Conference on September 13Printer Friendly Version
08/31/05Hospira Foundation Supports Hurricane Katrina Relief With Up To $300,000Printer Friendly Version
08/23/05Hospira Announces Plans To Close Plant In Donegal, IrelandPrinter Friendly Version
08/11/05Hospira Reports Second-Quarter 2005 ResultsPrinter Friendly Version
08/01/05Hospira Completes Physiometrix AcquisitionPrinter Friendly Version
07/20/05Hospira Ships First Orders Of Ceftriaxone InjectionPrinter Friendly Version
07/12/05Hospira Hosts Conference Call For Second-Quarter EarningsPrinter Friendly Version
06/01/05Hospira To Acquire PhysiometrixPrinter Friendly Version
05/12/05Hospira Reports First-Quarter 2005 ResultsPrinter Friendly Version
05/11/05Hospira to Present at the Banc of America Securities Health Care Conference on May 17Printer Friendly Version
05/10/05Hospira Introduces Wireless Version Of Its Hospira MedNet™ SystemPrinter Friendly Version
05/09/05Hospira Convenes Its First Annual Meeting of ShareholdersPrinter Friendly Version
04/11/05Hospira Hosts Conference Call For First-Quarter EarningsPrinter Friendly Version
04/01/05Hospira Nominates Judith C. Pelham, Former Trinity Health CEO, For Election To BoardPrinter Friendly Version
03/02/05Hospira Reports Fourth-Quarter and Full-Year 2004 ResultsPrinter Friendly Version
02/28/05Hospira And ICU Medical Sign Manufacturing, Commercialization And Development Agreement For Critical Care ProductsPrinter Friendly Version
02/14/05Hospira And Bridge Medical Announce Agreement To Develop New Medication Management Solution For Use At The Patient BedsidePrinter Friendly Version
02/03/05Hospira to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference On February 10Printer Friendly Version
01/25/05Hospira Announces Projections For 2005Printer Friendly Version
01/24/05Hospira Hosts Conference Calls For 2005 Projections And Fourth-Quarter EarningsPrinter Friendly Version
01/10/05Hospira to Present at the JPMorgan 23rd Annual Healthcare Conference on January 12Printer Friendly Version
12/30/04Hospira Supports Tsunami Disaster Relief With $300,000 And Medical Product DonationsPrinter Friendly Version
12/06/04ASHP Foundation And Hospira Announce Expanded Donor-Matching Program Printer Friendly Version
11/09/04Hospira Reports Third-Quarter 2004 ResultsPrinter Friendly Version
10/11/04Hospira Hosts Conference Call For Third-Quarter EarningsPrinter Friendly Version
09/23/04Hospira to Increase Its Non-DEHP Medical Device Portfolio by 50 PercentPrinter Friendly Version
09/09/04Hospira to Present at the Bear Stearns 17th Annual Healthcare Conference on September 13 Printer Friendly Version
08/25/04Hospira Expands Board of DirectorsPrinter Friendly Version
08/10/04Hospira Reports Second-Quarter 2004 ResultsPrinter Friendly Version
07/29/04Hospira Launches Fluconazole InjectionPrinter Friendly Version
07/26/04Hospira Joins The Generic Pharmaceutical AssociationPrinter Friendly Version
07/15/04Hospira And Consorta Enhance Medication Management PartnershipPrinter Friendly Version
07/12/04Hospira Hosts Conference Call For Second-Quarter EarningsPrinter Friendly Version
06/02/04Hospira Expands Manufacturing Capacity Through Purchase Of Fresenius Kabi's Clayton, N.C., FacilityPrinter Friendly Version
05/12/04Hospira Responds To Mini-Tender OfferPrinter Friendly Version
05/03/04Hospira Launches As New, Independent, Global Hospital Products CompanyPrinter Friendly Version